Last reviewed · How we verify
HRS4800
At a glance
| Generic name | HRS4800 |
|---|---|
| Sponsor | Jiangsu HengRui Medicine Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Efficacy and Safety of HRS4800 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery. (PHASE2)
- A Trial of HRS4800 Tables in Healthy Male Subjects (PHASE1)
- A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects (PHASE1)
- A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HRS4800 CI brief — competitive landscape report
- HRS4800 updates RSS · CI watch RSS
- Jiangsu HengRui Medicine Co., Ltd. portfolio CI